Article
Biochemistry & Molecular Biology
Hongzhuang Wen, Changbao Qu, Zhu Wang, Haitao Gao, Wuyao Liu, Hu Wang, Hao Sun, Junfei Gu, Zhan Yang, Xiaolu Wang
Summary: Cuproptosis, induced by copper ions, is associated with the progression and drug resistance of various tumors. This study investigated the role of cuproptosis in the chemotherapeutic resistance of prostate cancer to docetaxel. The findings suggest that cuproptosis can promote cell death and enhance chemosensitivity to docetaxel through the inhibition of autophagy and promotion of G2/M phase retention via the mTOR signaling pathway.
Article
Oncology
Zijin Zhao, Miaomiao Liu, Wenyong Long, Jian Yuan, Haoyu Li, Chi Zhang, Guodong Tang, Weixi Jiang, Xianrui Yuan, Minghua Wu, Qing Liu
Summary: CRNDE is a poor prognosis factor for GBM patients, upregulated in TMZ-resistant patients, and closely associated with chemotherapeutic response to TMZ treatment. Knockdown of CRNDE significantly reduces glioma cell viability and proliferation, enhances cell apoptosis, and improves sensitivity to TMZ treatment.
CANCER CELL INTERNATIONAL
(2021)
Article
Biochemistry & Molecular Biology
Chaima Cherif, Dang Tan Nguyen, Clement Paris, Thi Khanh Le, Thibaud Sefiane, Nadine Carbuccia, Pascal Finetti, Max Chaffanet, Abdessamad El Kaoutari, Julien Vernerey, Ladan Fazli, Martin Gleave, Mohamed Manai, Philippe Barthelemy, Daniel Birnbaum, Francois Bertucci, David Taieb, Palma Rocchi
Summary: Menin (MEN1) protein is highly regulated by HSP27, overexpressed in high-grade PC and CRPC, and high MEN1 mRNA expression is associated with decreased biochemical relapse-free and overall survival. Silencing Menin helps inhibit CRPC cell proliferation, tumor growth, and restore chemotherapeutic sensitivity.
Article
Medicine, Research & Experimental
Zengshu Xing, Sailian Li, Jiansheng Xing, Gang Yu, Guoren Wang, Zhenxiang Liu
Summary: The study demonstrates that LINC01963 is overexpressed in docetaxel-resistant prostate cancer cells and its silencing can enhance chemosensitivity, inhibit tumorigenicity and lung metastasis. LINC01963 exerts its effect by competitively binding to miR-216b-5p and reducing TrkB protein levels. These findings suggest that LINC01963 could be a potential therapeutic target for prostate cancer patients with docetaxel resistance.
LABORATORY INVESTIGATION
(2022)
Article
Biology
Teng Xue, Shujia Fei, Jian Gu, Nan Li, Pengxue Zhang, Xiaoqiu Liu, Paul R. Thompson, Xuesen Zhang
Summary: Inhibiting the activity of PADIs combined with Doc has an additive inhibitory effect on tumor cell growth and helps prevent the maintenance of cancer cell stemness.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
(2023)
Review
Biochemistry & Molecular Biology
Ashwin K. Chetty, Byung Hak Ha, Titus J. Boggon
Summary: This review focuses on the signaling pathways mediated by Rho family small GTPases and the specific roles of type II PAKs. The selectivity of Rho GTPases for PAK family members and the molecular basis for substrate recognition and regulation of signaling are discussed. The cross talk between Rho family small GTPases and the involvement of PAKs in diseases are also addressed.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2022)
Article
Oncology
Qiang Li, Zhili Liu, Luping Ma, Weiqi Yin, Kan Zhang
Summary: This study reveals that knockdown of CACYBP inhibits proliferation and migration and weakens tumor growth in prostate cancer.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Yazheng Dong, Xiao Wu, Xitong Peng, Liusong Yang, Baohua Tan, Huaxing Zhao, Enqin Zheng, Linjun Hong, Gengyuan Cai, Zhenfang Wu, Zicong Li
Summary: This study found that suppressing the expression of YY1 can improve the developmental ability of cloned pig embryos, providing a new method for increasing pig cloning efficiency.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Sandra M. Rocha, Daniel Nascimento, Rafaella S. Coelho, Ana Margarida Cardoso, Luis A. Passarinha, Silvia Socorro, Claudio J. Maia
Summary: This study aimed to evaluate the sensitivity of prostate cancer (PCa) cells to taxane-based drugs in response to STEAP1 gene expression. The results showed that STEAP1 knockdown or treatment with taxane-based drugs significantly reduced the viability and survival pathways of PCa cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, Research & Experimental
Zehua Ma, Weiwei Zhang, Baijun Dong, Zhixiang Xin, Yiyi Ji, Ruopeng Su, Kai Shen, Jiahua Pan, Qi Wang, Wei Xue
Summary: This study found that docetaxel-based chemohormonal therapy activates the immune response in prostate cancer and facilitates T cell infiltration, thereby improving the efficacy of anti-PD1 blockade therapy.
Article
Cell Biology
Wenjie Lai, Weian Zhu, Chutian Xiao, Xiaojuan Li, Yu Wang, Yuefu Han, Jiayu Zheng, Yingqiu Li, Mingqiang Li, Xingqiao Wen
Summary: Genes with cross-cancer aberrations, such as HJURP, play a potential role in cancer progression and could serve as therapeutic targets. Higher expression of HJURP is associated with poorer outcomes in prostate cancer patients, and its mechanism involves promoting cell proliferation by regulating CDKN1A ubiquitination levels.
CELL DEATH & DISEASE
(2021)
Article
Biochemistry & Molecular Biology
Kuen-Jang Tsai, Hsin-Yi Tsai, Chin-Chuan Tsai, Tai-Yu Chen, Tsung-Hua Hsieh, Chun-Lin Chen, Lulekiwe Mbuyisa, Yaw-Bin Huang, Ming-Wei Lin
Summary: Recent studies have shown that luteolin can inhibit the stemness of breast CSCs by downregulating the expression of Nrf2, and enhanced cytotoxicity to breast cancer cells when used in combination with the chemotherapeutic drug Taxol. Luteolin could be a potential agent for cancer stemness-targeted breast cancer treatments.
Article
Oncology
Katherine A. Giles, Cathryn M. Gould, Joanna Achinger-Kawecka, Scott G. Page, Georgia R. Kafer, Samuel Rogers, Phuc-Loi Luu, Anthony J. Cesare, Susan J. Clark, Phillippa C. Taberlay
Summary: The study found that BRG1 is overexpressed in prostate cancer and mainly affects global transcription programs by down-regulating gene expression, with most downregulated genes related to proliferation. Depletion of BRG1 results in G1 arrest.
CLINICAL EPIGENETICS
(2021)
Review
Oncology
Xiaodong Li, Feng Li
Summary: Gastrointestinal tumors are the most common tumors with high mortality rate worldwide. PAK, a serine/threonine kinase, plays a crucial role in tumor phenotype by influencing cell proliferation, survival, motility, tumor cell plasticity, and the tumor microenvironment. Understanding the features and signaling pathways of PAK in cells, especially its role in gastrointestinal tumors, can provide a theoretical basis for future research on PAK and potential therapeutic targets.
Article
Oncology
Yi Ma, Mehrdad Nikfarjam, Hong He
Summary: Pancreatic Ductal Adenocarcinoma (PDA) is a deadly cancer with KRAS mutation as a common oncogene. P21-activated kinases (PAKs) are downstream mediators of KRAS and play a role in PDA tumorigenesis. Inhibiting PAK reduces cancer cell viability and sensitizes them to chemotherapy. PAK inhibition also increases cancer immunogenicity in melanoma, glioblastoma, and PDA. Autophagy is important in PDA immune evasion and there is a connection between PAK and cancer cell autophagy.